Lumizyme Generic Name & Formulations
Legal Class
Rx
General Description
Alglucosidase alfa 50mg/vial; lyophilized pwd for IV infusion after reconstitution and dilution; preservative-free.
Pharmacological Class
Hydrolytic lysosomal glycogen-specific enzyme.
How Supplied
Single-use vial—1, 10
Manufacturer
Generic Availability
NO
Lumizyme Indications
Indications
Pompe disease (GAA deficiency).
Lumizyme Dosage and Administration
Adults and Children
Give by IV infusion over 4hrs. 20mg/kg every 2 weeks. Initial infusion rate: max 1mg/kg/hr; may increase by 2mg/kg/hr every 30mins, if tolerated, to max 7mg/kg/hr.
Lumizyme Contraindications
Not Applicable
Lumizyme Boxed Warnings
Boxed Warning
Risk of anaphylaxis, hypersensitivity, and immune-mediated reactions. Risk of cardiorespiratory failure.
Lumizyme Warnings/Precautions
Warnings/Precautions
Risk of anaphylaxis or severe hypersensitivity reactions; discontinue immediately if develop. Have appropriate medical support available and during rechallenge. Monitor for systemic immune-mediated reactions; consider discontinuing and treat if occur. Obtain urinalysis periodically. Acute underlying respiratory illness or compromised cardiac and/or respiratory function: risk of acute cardiorespiratory failure. Cardiac hypertrophy (increased risk of cardiac arrhythmia when given general anesthesia for central venous catheter placement). Infants with cardiac dysfunction may require prolonged observation times. Risk of antibody development. Infantile-onset disease: perform cross-reactive immunologic material (CRIM) assessment early in the disease course. Monitor for IgG antibody formation every 3 months for 2 years, then annually. Labor & delivery. Pregnancy. Nursing mothers (consider interrupting breastfeeding, pumping and discarding breast milk during and for 24hrs after therapy).
Lumizyme Pharmacokinetics
See Literature
Lumizyme Interactions
Not Applicable
Lumizyme Adverse Reactions
Adverse Reactions
Hypersensitivity reactions (including anaphylaxis, rash, pyrexia, flushing/feeling hot, urticaria, headache, hyperhidrosis, nausea, cough, decreased oxygen saturation, tachycardia, tachypnea, chest discomfort, dizziness, muscle twitching, agitation, cyanosis, erythema, hypertension, pallor, rigors, tremor, vomiting, fatigue, myalgia).
Lumizyme Clinical Trials
See Literature
Lumizyme Note
Notes
To enroll in the Pompe registry call (800) 745-4447.
Lumizyme Patient Counseling
See Literature